RxDoctor Payments Data

Rachel Brucas

Physician Assistant · Evergreen Park, ILNPI 1457894768

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 698 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 48 manufacturers reported payments, led by AbbVie at 39.4% of the total. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,406in general payments, 2019–2025

Across 698 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • AstraZeneca$924
  • Boehringer Ingelheim$602
  • Pfizer$581
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$14,372100%
  • Education$350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,406 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide22$33,229
OzempicSemaglutide16$24,659
EliquisApixaban17$20,818
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,451
Atorvastatin Calcium109$1,237
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf15$1,033
SynthroidLevothyroxine Sodium17$909
Rosuvastatin Calcium46$645
Losartan Potassium48$618
Omeprazole27$471
Levothyroxine Sodium47$430
Amlodipine Besylate76$405
Levocetirizine Dihydrochloride16$380
Albuterol Sulfate HfaAlbuterol Sulfate20$329
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide22$328

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,193$33,22922 claims
Novo NordiskOzempic$559$24,65916 claims
PfizerEliquis$581$20,81817 claims
GSKTrelegy Ellipta$487$12,45111 claims
AbbVieSynthroid$5,679$90917 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$43047 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Evergreen Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →